ANTIPHOSPHOLIPID ANTIBODIES IN WOMEN WITH PLACENTAL INSUFFICIENCY
DOI:
https://doi.org/10.34921/amj.2022.2.013Keywords:
antiphospholipid antibodies, placental insufficiency, enzyme immunoassayAbstract
The article presents the results of studying the presence of various antiphospholipid antibodies and their frequency in women with placental insufficiency. The study involved 83 women with singleton pregnancies (average age 29.9 ± 3.06 years), who were divided into 2 groups: the main group - 58 pregnant women with placental insufficiency; control group – 25 pregnant women without placental insufficiency. The presence of antiphospholipid antibodies was determined using immunometric tests and a functional coagulation test for lupus anticoagulant. In patients with placental insufficiency, a positive result of lupus anticoagulant was detected in 73.1% of cases, antibodies to cardiolipin - 46.2%, and antibodies to β2-glycoprotein I in 15.4% of cases. This study confirms the high prevalence of antiphospholipid antibodies in women with placental insufficiency. Testing in this high-risk group can improve fetal, maternal and newborn outcomes and may lead to better outcomes in future pregnancies.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Azerbaijan Medical Journal

This work is licensed under a Creative Commons Attribution 4.0 International License.


